BBGBloomberg·3hHealth
score+0.70
Genmab Soars as Cancer Drug Impresses in a Late-Stage Trial
Original
Genmab Soars as Cancer Drug Impresses in a Late-Stage Trial
“Positive business news framing highlights stock surge and successful clinical trial results exceeding expectations.”